Assembly Biosciences

11711 North Meridian Street
Suite 310
Indianapolis
Indiana
46032
United States

Tel: 855.971.4467

Email: info@assemblybio.com

Show jobs for this employer

About Assembly Biosciences

Assembly Biosciences, Inc. is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live synthetic biotherapeutic candidates with Assembly’s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. For more information, visit assemblybio.com.

Stock Exchange: NASDAQ

Stock Symbol: ASMB

R & D Main Facility:

Assembly Biosciences

331 Oyster Point Blvd.

South San Francisco, CA  94080

22 articles with Assembly Biosciences